Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New varicella vaccines

¹Merck Research Laboratories, West Point, Pennsylvania, USA.

Infectious Disease Clinics of North America

|September 1, 1996

Summary

This summary is machine-generated.

The live attenuated varicella vaccine prevents chickenpox using classic technology. Newer vaccine technologies offer potential advantages and disadvantages compared to the current varicella vaccine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Veterinary Medical Association of New York County.

The Journal of comparative medicine and veterinary archives·2022

Same author

Veterinary Dentist.

The Journal of comparative medicine and veterinary archives·2022

Same author

The applications of synthetic oligonucleotides to molecular biology.

Pharmaceutical research·2013

Same author

Comparison of some properties of beef from animals homozygous or heterozygous for muscular hypertrophy.

Meat science·2011

Same author

Comparison of some properties of meat from normal steers and steers heterozygous for muscular hypertrophy.

Meat science·2011

Same author

THE VERNES REACTION: REPORT ON A THOUSAND SERA.

The British journal of venereal diseases·2011

Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026

Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026

Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026

Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026

Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026

Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026

See all related articles

Area of Science:

Vaccinology
Immunology
Virology

Background:

The current live attenuated varicella vaccine for chickenpox prevention utilizes classic vaccine production technology.
This established technology is also employed in the manufacturing of vaccines for polio, measles, mumps, and rubella.

Purpose of the Study:

To compare the classic technology used for varicella vaccine production with newer vaccine development approaches.
To evaluate the potential advantages and disadvantages of emerging vaccine technologies in relation to the existing varicella vaccine.

Main Methods:

Review of established vaccine production technologies.
Analysis of emerging vaccine research and development methodologies.
Comparative assessment of technological approaches in vaccinology.

Related Experiment Videos

Main Results:

Classic vaccine technology, while effective for varicella, represents an older methodology.
Numerous novel technologies are being explored for vaccine development, offering diverse potential benefits.
Each technological approach presents a unique profile of advantages and limitations.

Conclusions:

The landscape of vaccine technology is evolving beyond classic methods.
Newer technologies hold promise for future vaccine development, including potential improvements for varicella prevention.
A thorough understanding of both existing and emerging technologies is crucial for advancing vaccine science.